Compare Medtronic PLC (MDT) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Medpace Holdings Inc — how do they compare? Medtronic PLC trades at $82.79 (market cap $106.61B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: Medtronic PLC is far larger — about 7.1× Medpace Holdings Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MDT | MEDP | |
|---|---|---|
Market Cap | $106.61B | $15.08B |
Sector | Health | Technology |
52-Week High | $105.35 | $620.59 |
52-Week Low | $73.75 | $308.88 |
Enterprise Value | $125.36B | $14.55B |
Dividend Yield | 3.46% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
